BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -99.8% | 179 | -99.8% | 0.00% | -100.0% |
| Q4 2020 | $5,982,000 | -74.7% | 74,561 | -74.6% | 0.02% | -75.3% |
| Q3 2020 | $23,623,000 | +4399.6% | 293,754 | +4715.6% | 0.10% | +4750.0% |
| Q2 2020 | $525,000 | -91.2% | 6,100 | -91.7% | 0.00% | -92.9% |
| Q1 2020 | $5,996,000 | -5.9% | 73,850 | -3.1% | 0.03% | +27.3% |
| Q4 2019 | $6,373,000 | +12155.8% | 76,208 | +12015.7% | 0.02% | – |
| Q2 2019 | $52,000 | -94.4% | 629 | -94.5% | 0.00% | -100.0% |
| Q1 2019 | $933,000 | -90.9% | 11,464 | -92.6% | 0.01% | -92.2% |
| Q4 2018 | $10,210,000 | -39.3% | 155,119 | -28.9% | 0.06% | -44.3% |
| Q3 2018 | $16,818,000 | +2333.9% | 218,155 | +2230.2% | 0.12% | +2775.0% |
| Q2 2018 | $691,000 | -61.9% | 9,362 | -66.4% | 0.00% | -71.4% |
| Q1 2018 | $1,813,000 | -58.1% | 27,884 | -58.3% | 0.01% | -56.2% |
| Q4 2017 | $4,326,000 | +219.3% | 66,931 | +156.2% | 0.03% | +146.2% |
| Q1 2017 | $1,355,000 | -95.6% | 26,124 | -96.2% | 0.01% | -95.7% |
| Q4 2016 | $30,675,000 | +5338.8% | 691,821 | +5746.0% | 0.30% | +3650.0% |
| Q3 2016 | $564,000 | +83.7% | 11,834 | +74.0% | 0.01% | +60.0% |
| Q2 2016 | $307,000 | -78.5% | 6,800 | -80.4% | 0.01% | -81.5% |
| Q1 2016 | $1,428,000 | +0.4% | 34,762 | -6.8% | 0.03% | -6.9% |
| Q4 2015 | $1,423,000 | +4.1% | 37,303 | -10.3% | 0.03% | -17.1% |
| Q3 2015 | $1,367,000 | +9.2% | 41,600 | +132.4% | 0.04% | +16.7% |
| Q2 2015 | $1,252,000 | -4.8% | 17,900 | -6.8% | 0.03% | -9.1% |
| Q1 2015 | $1,315,000 | -91.5% | 19,200 | -90.9% | 0.03% | -92.3% |
| Q4 2014 | $15,384,000 | +75.4% | 209,900 | +71.8% | 0.43% | +84.1% |
| Q3 2014 | $8,769,000 | +89.0% | 122,194 | +90.4% | 0.23% | +124.0% |
| Q2 2014 | $4,640,000 | -73.9% | 64,182 | -73.4% | 0.10% | -71.1% |
| Q1 2014 | $17,762,000 | +79.6% | 241,400 | +69.8% | 0.36% | +52.5% |
| Q4 2013 | $9,890,000 | -10.3% | 142,200 | -15.3% | 0.24% | -36.4% |
| Q3 2013 | $11,030,000 | +21.2% | 167,922 | +27.8% | 0.37% | +5.7% |
| Q2 2013 | $9,102,000 | +26.1% | 131,399 | +32.3% | 0.35% | -2.0% |
| Q1 2013 | $7,217,000 | -64.6% | 99,350 | -67.6% | 0.36% | -79.7% |
| Q4 2012 | $20,409,000 | – | 306,164 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |